ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Caixin

China's Fosun to import 7.2m doses of BioNTech-Pfizer COVID vaccine

Company working with airlines to start shipments in January

Fosun is arranging logistics with several airlines to start transporting the vaccine from BioNTech’s German factory to China starting in January.    © Reuters

BioNTech's Chinese partner Shanghai Fosun Pharmaceutical Group plans to import 7.2 million doses of the German company's COVID-19 vaccine in the first half of 2021, Caixin learned from several people familiar with the company's plan.

Fosun is arranging logistics with several airlines to start transporting the vaccine from BioNTech's German factory to China starting in January. Based on available data, the company can import 1.2 million doses a month, the people said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more